How egg-freezing is keeping more women in the tech industry: The inside story
By Alison DeNisco,
Tech Republic [cites CGS' Marcy Darnovsky]
| 08. 15. 2017
Women leave jobs at mid-career in tech at higher rates than those in other fields. It's possible that benefits like egg freezing can improve female retention, but the procedure remains controversial.
At Brigitte Adams' last job in tech, an office lactation room was turned into a prayer room. "There were no pregnant women at the company, ever," she said. "I was surrounded by men in engineering departments. You didn't see other women."
In the summer of 2011, Adams had just left a multinational corporation to become a consultant. She was 39 years old and not yet married, and began thinking about making plans for a future family. "It was sort of a typical scenario of a single career woman who really wanted kids," she said. Being a tech-minded person, she turned to a procedure that was at the time still labeled experimental: Egg freezing. Also known as oocyte cryopreservation, egg freezing is a process in which a woman's eggs are extracted, frozen, and stored for future use, as a way to preserve their reproductive potential.
It's been nearly three...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...